Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Personalized pharmacokinetic targeting with busulfan in allogeneic hematopoietic stem cell transplantation in infants with acute lymphoblastic leukemia.

Takachi T, Arakawa Y, Nakamura H, Watanabe T, Aoki Y, Ohshima J, Takahashi Y, Hirayama M, Miyamura T, Sugita K, Koh K, Horibe K, Ishii E, Mizutani S, Tomizawa D.

Int J Hematol. 2019 Jun 14. doi: 10.1007/s12185-019-02684-0. [Epub ahead of print]

PMID:
31201644
2.

A novel KMT2A-ACTN2 fusion in infant B-cell acute lymphoblastic leukemia.

Yoshida M, Nakabayashi K, Ogata-Kawata H, Osumi T, Tsujimoto SI, Shirai R, Yoshida K, Okamura K, Matsumoto K, Kiyokawa N, Tomizawa D, Hata K, Kato M.

Pediatr Blood Cancer. 2019 May 21:e27821. doi: 10.1002/pbc.27821. [Epub ahead of print] No abstract available.

PMID:
31115144
3.

Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Iacobucci I, Wen J, Meggendorfer M, Choi JK, Shi L, Pounds SB, Carmichael CL, Masih KE, Morris SM, Lindsley RC, Janke LJ, Alexander TB, Song G, Qu C, Li Y, Payne-Turner D, Tomizawa D, Kiyokawa N, Valentine M, Valentine V, Basso G, Locatelli F, Enemark EJ, Kham SKY, Yeoh AEJ, Ma X, Zhou X, Sioson E, Rusch M, Ries RE, Stieglitz E, Hunger SP, Wei AH, To LB, Lewis ID, D'Andrea RJ, Kile BT, Brown AL, Scott HS, Hahn CN, Marlton P, Pei D, Cheng C, Loh ML, Ebert BL, Meshinchi S, Haferlach T, Mullighan CG.

Nat Genet. 2019 Apr;51(4):694-704. doi: 10.1038/s41588-019-0375-1. Epub 2019 Mar 29.

PMID:
30926971
4.

Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.

Ikeda J, Shiba N, Tsujimoto SI, Yoshida M, Nakabayashi K, Ogata-Kawata H, Okamura K, Takeuchi M, Osumi T, Tomizawa D, Hata K, Kiyokawa N, Ito S, Kato M.

Genes Chromosomes Cancer. 2019 Mar 14. doi: 10.1002/gcc.22751. [Epub ahead of print]

PMID:
30869817
5.

Successful Treatment With ATRA and Arsenic Trioxide for a Child With Down Syndrome and Acute Promyelocytic Leukemia.

Tsumura Y, Yamada Y, Osumi T, Kato M, Terashima K, Shioda Y, Kiyotani C, Matsumoto K, Tomizawa D.

J Pediatr Hematol Oncol. 2019 Feb 22. doi: 10.1097/MPH.0000000000001438. [Epub ahead of print]

PMID:
30807394
6.

Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.

Miyamura T, Moritake H, Nakayama H, Tanaka S, Tomizawa D, Shiba N, Saito AM, Tawa A, Shimada A, Iwamoto S, Hayashi Y, Koike T, Horibe K, Manabe A, Mizutani S, Taga T, Adachi S.

Br J Haematol. 2019 Apr;185(2):284-288. doi: 10.1111/bjh.15799. Epub 2019 Feb 19.

PMID:
30784060
7.

Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia.

Okamoto Y, Kudo K, Tabuchi K, Tomizawa D, Taga T, Goto H, Yabe H, Nakazawa Y, Koh K, Ikegame K, Yoshida N, Uchida N, Watanabe K, Koga Y, Inoue M, Kato K, Atsuta Y, Ishida H.

Bone Marrow Transplant. 2019 Feb 4. doi: 10.1038/s41409-019-0461-0. [Epub ahead of print]

PMID:
30718800
8.

Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.

Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S.

Blood Adv. 2018 Nov 13;2(21):2879-2889. doi: 10.1182/bloodadvances.2018019398.

9.

The genetic basis and cell of origin of mixed phenotype acute leukaemia.

Alexander TB, Gu Z, Iacobucci I, Dickerson K, Choi JK, Xu B, Payne-Turner D, Yoshihara H, Loh ML, Horan J, Buldini B, Basso G, Elitzur S, de Haas V, Zwaan CM, Yeoh A, Reinhardt D, Tomizawa D, Kiyokawa N, Lammens T, De Moerloose B, Catchpoole D, Hori H, Moorman A, Moore AS, Hrusak O, Meshinchi S, Orgel E, Devidas M, Borowitz M, Wood B, Heerema NA, Carrol A, Yang YL, Smith MA, Davidsen TM, Hermida LC, Gesuwan P, Marra MA, Ma Y, Mungall AJ, Moore RA, Jones SJM, Valentine M, Janke LJ, Rubnitz JE, Pui CH, Ding L, Liu Y, Zhang J, Nichols KE, Downing JR, Cao X, Shi L, Pounds S, Newman S, Pei D, Guidry Auvil JM, Gerhard DS, Hunger SP, Inaba H, Mullighan CG.

Nature. 2018 Oct;562(7727):373-379. doi: 10.1038/s41586-018-0436-0. Epub 2018 Sep 12.

10.

Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.

Noort S, Zimmermann M, Reinhardt D, Cuccuini W, Pigazzi M, Smith J, Ries RE, Alonzo TA, Hirsch B, Tomizawa D, Locatelli F, Gruber TA, Raimondi S, Sonneveld E, Cheuk DK, Dworzak M, Stary J, Abrahamsson J, Arad-Cohen N, Czogala M, De Moerloose B, Hasle H, Meshinchi S, van den Heuvel-Eibrink M, Zwaan CM.

Blood. 2018 Oct 11;132(15):1584-1592. doi: 10.1182/blood-2018-05-849059. Epub 2018 Aug 27.

PMID:
30150206
11.

Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms.

Tsujimoto S, Osumi T, Uchiyama M, Shirai R, Moriyama T, Nishii R, Yamada Y, Kudo K, Sekiguchi M, Arakawa Y, Yoshida M, Uchiyama T, Terui K, Ito S, Koh K, Takita J, Ito E, Tomizawa D, Manabe A, Kiyokawa N, Yang JJ, Kato M.

Leukemia. 2018 Dec;32(12):2710-2714. doi: 10.1038/s41375-018-0190-1. Epub 2018 Jul 2. No abstract available.

12.

A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning.

Osumi T, Tomizawa D, Kawai T, Sako M, Inoue E, Takimoto T, Tamura E, Uchiyama T, Imadome KI, Taniguchi M, Shirai R, Yoshida M, Ando R, Tsumura Y, Fuji H, Matsumoto K, Shioda Y, Kiyotani C, Terashima K, Onodera M, Matsumoto K, Kato M.

Bone Marrow Transplant. 2019 Jan;54(1):168-172. doi: 10.1038/s41409-018-0271-9. Epub 2018 Jun 29. No abstract available.

PMID:
29959437
13.

Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.

Tomizawa D, Yoshida M, Kondo T, Miyamura T, Taga T, Adachi S, Koh K, Noguchi M, Kakuda H, Watanabe K, Cho Y, Fukuda T, Kato M, Shiba N, Goto H, Okada K, Inoue M, Hashii Y, Atsuta Y, Ishida H.

Bone Marrow Transplant. 2019 Mar;54(3):393-401. doi: 10.1038/s41409-018-0273-7. Epub 2018 Jun 29.

PMID:
29959436
14.

Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation.

Osumi T, Tsujimoto SI, Tamura M, Uchiyama M, Nakabayashi K, Okamura K, Yoshida M, Tomizawa D, Watanabe A, Takahashi H, Hori T, Yamamoto S, Hamamoto K, Migita M, Ogata-Kawata H, Uchiyama T, Kizawa H, Ueno-Yokohata H, Shirai R, Seki M, Ohki K, Takita J, Inukai T, Ogawa S, Kitamura T, Matsumoto K, Hata K, Kiyokawa N, Goyama S, Kato M.

Cancer Res. 2018 Aug 15;78(16):4452-4458. doi: 10.1158/0008-5472.CAN-18-0840. Epub 2018 Jun 19.

PMID:
29921692
15.

Evaluation of high-dose cytarabine in induction therapy for children with de novo acute myeloid leukemia: a study protocol of the Japan Children's Cancer Group Multi-Center Seamless Phase II-III Randomized Trial (JPLSG AML-12).

Tomizawa D, Tanaka S, Hasegawa D, Iwamoto S, Hiramatsu H, Kiyokawa N, Miyachi H, Horibe K, Saito AM, Taga T, Adachi S.

Jpn J Clin Oncol. 2018 Jun 1;48(6):587-593. doi: 10.1093/jjco/hyy061.

PMID:
29889285
16.

Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission.

Noguchi Y, Tomizawa D, Hiroki H, Miyamoto S, Tezuka M, Miyawaki R, Tanaka-Kubota M, Okano T, Kobayashi C, Mitsuiki N, Aoki Y, Imai K, Kajiwara M, Kanegane H, Morio T, Takagi M.

Clin Case Rep. 2018 Apr 10;6(6):1023-1028. doi: 10.1002/ccr3.1506. eCollection 2018 Jun.

17.

Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.

Kato M, Kurata M, Kanda J, Kato K, Tomizawa D, Kudo K, Yoshida N, Watanabe K, Shimada H, Inagaki J, Koh K, Goto H, Kato K, Cho Y, Yuza Y, Ogawa A, Okada K, Inoue M, Hashii Y, Teshima T, Murata M, Atsuta Y.

Bone Marrow Transplant. 2019 Jan;54(1):68-75. doi: 10.1038/s41409-018-0221-6. Epub 2018 May 24.

PMID:
29795428
18.

Total body irradiation for hematopoietic stem cell transplantation during early childhood is associated with the risk for diabetes mellitus.

Nakagawa R, Hosokawa-Tsuji A, Aoki Y, Takasawa K, Maru M, Nakajima K, Sutani A, Miyakawa Y, Tomizawa D, Kashimada K, Morio T.

Endocrine. 2018 Jul;61(1):76-82. doi: 10.1007/s12020-018-1595-3. Epub 2018 Apr 24.

PMID:
29691808
19.

Successful treatment of systemic EBV positive T-cell lymphoma of childhood using the SMILE regimen.

Yoshida M, Osumi T, Imadome KI, Tomizawa D, Kato M, Miyazawa N, Ito R, Nakazawa A, Matsumoto K.

Pediatr Hematol Oncol. 2018 Mar;35(2):121-124. doi: 10.1080/08880018.2018.1459982. Epub 2018 Apr 12. No abstract available.

PMID:
29648917
20.

Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.

Takahashi H, Kajiwara R, Kato M, Hasegawa D, Tomizawa D, Noguchi Y, Koike K, Toyama D, Yabe H, Kajiwara M, Fujimura J, Sotomatsu M, Ota S, Maeda M, Goto H, Kato Y, Mori T, Inukai T, Shimada H, Fukushima K, Ogawa C, Makimoto A, Fukushima T, Ohki K, Koh K, Kiyokawa N, Manabe A, Ohara A.

Int J Hematol. 2018 Jul;108(1):98-108. doi: 10.1007/s12185-018-2440-4. Epub 2018 Mar 27.

PMID:
29589281
21.

RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis.

Yamato G, Shiba N, Yoshida K, Hara Y, Shiraishi Y, Ohki K, Okubo J, Park MJ, Sotomatsu M, Arakawa H, Kiyokawa N, Tomizawa D, Adachi S, Taga T, Horibe K, Miyano S, Ogawa S, Hayashi Y.

Blood. 2018 May 17;131(20):2266-2270. doi: 10.1182/blood-2017-11-814442. Epub 2018 Mar 14. No abstract available.

22.

Somatic MECOM mosaicism in a patient with congenital bone marrow failure without a radial abnormality.

Osumi T, Tsujimoto SI, Nakabayashi K, Taniguchi M, Shirai R, Yoshida M, Uchiyama T, Nagasawa J, Goyama S, Yoshioka T, Tomizawa D, Kurokawa M, Matsubara Y, Kiyokawa N, Matsumoto K, Hata K, Kato M.

Pediatr Blood Cancer. 2018 Jun;65(6):e26959. doi: 10.1002/pbc.26959. Epub 2018 Jan 22. No abstract available.

PMID:
29356389
23.

Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.

Shimada A, Iijima-Yamashita Y, Tawa A, Tomizawa D, Yamada M, Norio S, Watanabe T, Taga T, Iwamoto S, Terui K, Moritake H, Kinoshita A, Takahashi H, Nakayama H, Koh K, Goto H, Kosaka Y, Saito AM, Kiyokawa N, Horibe K, Hara Y, Oki K, Hayashi Y, Tanaka S, Adachi S.

Int J Hematol. 2018 May;107(5):586-595. doi: 10.1007/s12185-017-2395-x. Epub 2018 Jan 12.

PMID:
29330746
24.

Multiplex fusion gene testing in pediatric acute myeloid leukemia.

Iijima-Yamashita Y, Matsuo H, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Takahashi H, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K.

Pediatr Int. 2018 Jan;60(1):47-51. doi: 10.1111/ped.13451.

PMID:
29105243
25.

Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.

Matsuo H, Iijima-Yamashita Y, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K.

Pediatr Int. 2018 Jan;60(1):41-46. doi: 10.1111/ped.13440.

PMID:
29067751
26.

Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.

Kuwatsuka Y, Tomizawa D, Kihara R, Nagata Y, Shiba N, Iijima-Yamashita Y, Shimada A, Deguchi T, Miyachi H, Tawa A, Taga T, Kinoshita A, Nakayama H, Kiyokawa N, Saito AM, Koh K, Goto H, Kosaka Y, Asou N, Ohtake S, Miyawaki S, Miyazaki Y, Sakura T, Ozawa Y, Usui N, Kanamori H, Ito Y, Imai K, Suehiro Y, Kobayashi S, Kitamura K, Sakaida E, Ogawa S, Naoe T, Hayashi Y, Horibe K, Manabe A, Mizutani S, Adachi S, Kiyoi H.

Int J Hematol. 2018 Feb;107(2):201-210. doi: 10.1007/s12185-017-2340-z. Epub 2017 Oct 12.

PMID:
29027108
27.

Acute leukemia in adolescents and young adults.

Tomizawa D.

Rinsho Ketsueki. 2017;58(10):2160-2167. doi: 10.11406/rinketsu.58.2160. Japanese.

PMID:
28978861
28.

Acute myeloid leukemia in adolescents and young adults: from the viewpoint of pediatricians.

Tomizawa D, Adachi S.

Rinsho Ketsueki. 2017;58(8):1038-1046. doi: 10.11406/rinketsu.58.1038. Japanese.

PMID:
28883267
29.

Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia.

Nakayama H, Tomizawa D, Tanaka S, Iwamoto S, Shimada A, Saito AM, Yamashita Y, Moritake H, Terui K, Taga T, Matsuo H, Kosaka Y, Koh K, Hosoi H, Kurosawa H, Isoyama K, Horibe K, Mizutani S, Adachi S.

Pediatr Int. 2017 Oct;59(10):1046-1052. doi: 10.1111/ped.13378.

PMID:
28771903
30.

Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.

Chijimatsu I, Imanaka Y, Tomizawa D, Eguchi M, Nishimura S, Karakawa S, Miki M, Hamamoto K, Fujita N.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26697. Epub 2017 Jul 4.

PMID:
28675638
31.

Down syndrome and AML: where do we go from here?

Tomizawa D, Kolb EA.

Blood. 2017 Jun 22;129(25):3274-3275. doi: 10.1182/blood-2017-04-780031. No abstract available.

32.

Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid Leukemia.

Tomizawa D, Tanaka S, Kondo T, Hashii Y, Arai Y, Kudo K, Taga T, Fukuda T, Goto H, Inagaki J, Koh K, Ohashi K, Ozawa Y, Inoue M, Kato K, Tanaka J, Atsuta Y, Adachi S, Ishida H.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1515-1522. doi: 10.1016/j.bbmt.2017.05.009. Epub 2017 May 10.

33.

Resolution of liver disease in transient abnormal myelopoiesis with fish oil emulsion.

Watanabe T, Amari S, Tsukamoto K, Ito Y, Tomizawa D, Yoshioka T, Kanamori Y.

Pediatr Int. 2017 Apr;59(4):515-518. doi: 10.1111/ped.13250.

PMID:
28401746
34.

Plasma asparaginase activity, asparagine concentration, and toxicity after administration of Erwinia asparaginase in children and young adults with acute lymphoblastic leukemia: Phase I/II clinical trial in Japan.

Ogawa C, Taguchi F, Goto H, Koh K, Tomizawa D, Ohara A, Manabe A.

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26475. Epub 2017 Feb 28.

PMID:
28244643
35.

Blastic transformation of juvenile myelomonocytic leukemia caused by the copy number gain of oncogenic KRAS.

Osumi T, Kato M, Ouchi-Uchiyama M, Tomizawa D, Kataoka K, Fujii Y, Seki M, Takita J, Ogawa S, Uchiyama T, Ohki K, Kiyokawa N.

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26496. Epub 2017 Feb 28.

PMID:
28244637
36.

Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study.

Moritake H, Tanaka S, Nakayama H, Miyamura T, Iwamoto S, Shimada A, Terui K, Saito A, Shiba N, Hayashi Y, Tomizawa D, Taga T, Goto H, Hasegawa D, Horibe K, Mizutani S, Adachi S.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26491. Epub 2017 Feb 24. No abstract available.

PMID:
28233452
37.

HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy.

Takagi M, Ishiwata Y, Aoki Y, Miyamoto S, Hoshino A, Matsumoto K, Nishimura A, Tanaka M, Yanagimachi M, Mitsuiki N, Imai K, Kanegane H, Kajiwara M, Takikawa K, Mae T, Tomita O, Fujimura J, Yasuhara M, Tomizawa D, Mizutani S, Morio T.

Int J Hematol. 2017 May;105(5):686-691. doi: 10.1007/s12185-017-2187-3. Epub 2017 Feb 9.

PMID:
28185203
38.

ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.

Yamato G, Shiba N, Yoshida K, Shiraishi Y, Hara Y, Ohki K, Okubo J, Okuno H, Chiba K, Tanaka H, Kinoshita A, Moritake H, Kiyokawa N, Tomizawa D, Park MJ, Sotomatsu M, Taga T, Adachi S, Tawa A, Horibe K, Arakawa H, Miyano S, Ogawa S, Hayashi Y.

Genes Chromosomes Cancer. 2017 May;56(5):382-393. doi: 10.1002/gcc.22443. Epub 2017 Feb 14.

PMID:
28063196
39.

Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.

Hara Y, Shiba N, Ohki K, Tabuchi K, Yamato G, Park MJ, Tomizawa D, Kinoshita A, Shimada A, Arakawa H, Saito AM, Kiyokawa N, Tawa A, Horibe K, Taga T, Adachi S, Taki T, Hayashi Y.

Genes Chromosomes Cancer. 2017 May;56(5):394-404. doi: 10.1002/gcc.22444. Epub 2017 Feb 14.

PMID:
28063190
40.

Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia.

Tomizawa D, Endo A, Kajiwara M, Sakaguchi H, Matsumoto K, Kaneda M, Taga T.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26411. Epub 2016 Dec 24.

PMID:
28012245
41.

Transmission of chromosomally integrated human herpesvirus 6 via cord blood transplantation.

Yamada Y, Osumi T, Imadome KI, Takahashi E, Ohye T, Yoshikawa T, Tomizawa D, Kato M, Matsumoto K.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12636. Epub 2016 Dec 25.

PMID:
27859994
42.

Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.

Shiba N, Yoshida K, Shiraishi Y, Okuno Y, Yamato G, Hara Y, Nagata Y, Chiba K, Tanaka H, Terui K, Kato M, Park MJ, Ohki K, Shimada A, Takita J, Tomizawa D, Kudo K, Arakawa H, Adachi S, Taga T, Tawa A, Ito E, Horibe K, Sanada M, Miyano S, Ogawa S, Hayashi Y.

Br J Haematol. 2016 Nov;175(3):476-489. doi: 10.1111/bjh.14247. Epub 2016 Jul 29.

PMID:
27470916
43.

Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children.

Kato M, Ishimaru S, Seki M, Yoshida K, Shiraishi Y, Chiba K, Kakiuchi N, Sato Y, Ueno H, Tanaka H, Inukai T, Tomizawa D, Hasegawa D, Osumi T, Arakawa Y, Aoki T, Okuya M, Kaizu K, Kato K, Taneyama Y, Goto H, Taki T, Takagi M, Sanada M, Koh K, Takita J, Miyano S, Ogawa S, Ohara A, Tsuchida M, Manabe A.

Leukemia. 2017 Mar;31(3):580-584. doi: 10.1038/leu.2016.274. Epub 2016 Oct 4.

PMID:
27698447
44.

Ocular manifestation in myeloid/NK cell precursor acute leukemia: a case report. Diagnosed by flow cytometry and PCR from aqueous humor.

Akaike S, Kamoi K, Tezuka M, Tomizawa D, Yoshimura R, Takagi M, Ohno-Matsui K.

Medicine (Baltimore). 2016 Sep;95(38):e4967. doi: 10.1097/MD.0000000000004967.

45.

EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway.

Endo A, Tomizawa D, Aoki Y, Morio T, Mizutani S, Takagi M.

Cancer Sci. 2016 Dec;107(12):1745-1754. doi: 10.1111/cas.13080. Epub 2016 Nov 25.

46.

CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.

Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S.

Pediatr Blood Cancer. 2016 Aug;63(8):1394-9. doi: 10.1002/pbc.26035. Epub 2016 May 2.

PMID:
27135782
47.

[LMB chemotherapy for mature B-cell neoplasms in children: a single-center experience].

Osumi T, Mori T, Shioda Y, Kiyotani C, Terashima K, Kato M, Tomizawa D, Ohki K, Kiyokawa N, Iwafuchi H, Yoshioka T, Nakazawa A, Matsumoto K.

Rinsho Ketsueki. 2016 Mar;57(3):346-52. doi: 10.11406/rinketsu.57.346. Japanese.

PMID:
27076248
48.

Pediatric Thromboembolism in Japan.

Tetsuhara K, Ishiguro A, Michihata N, Sensaki S, Nakadate H, Kimura Y, Tomizawa D, Matsumoto K.

Indian J Pediatr. 2016 Oct;83(10):1077-81. doi: 10.1007/s12098-016-2094-2. Epub 2016 Apr 7.

PMID:
27053184
49.

High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group.

Takahashi H, Watanabe T, Kinoshita A, Yuza Y, Moritake H, Terui K, Iwamoto S, Nakayama H, Shimada A, Kudo K, Taki T, Yabe M, Matsushita H, Yamashita Y, Koike K, Ogawa A, Kosaka Y, Tomizawa D, Taga T, Saito AM, Horibe K, Nakahata T, Miyachi H, Tawa A, Adachi S.

Br J Haematol. 2016 Aug;174(3):437-43. doi: 10.1111/bjh.14068. Epub 2016 Mar 31.

PMID:
27029412
50.

Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.

Keino D, Kinoshita A, Tomizawa D, Takahashi H, Ida K, Kurosawa H, Koike K, Ota S, Iwasaki N, Fujimura J, Yuza Y, Kiyotani C, Yamamoto S, Osumi T, Ueda T, Mochizuki S, Isoyama K, Hanada R, Tawa A, Manabe A, Toguchi Y, Ohara A.

Int J Hematol. 2016 Apr;103(4):416-22. doi: 10.1007/s12185-016-1937-y. Epub 2016 Jan 18.

PMID:
26781613

Supplemental Content

Loading ...
Support Center